Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Backed by clinical research as an effective option for individuals with obesity or weight-related health conditions
References: FDA Mounjaro Approval, FDA Zepbound Approval Indications and Contraindications Approved Uses Type 2 diabetes mellitus (as an adjunct to diet and exercise) Chronic weight management in adults with BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity Contraindications Personal or family history of medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Hypersensitivity to tirzepatide or any component of the formulation Note: Tirzepatide is not indicated for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis
Trulicity is administered once a week as injection under the skin
Patients should follow all instructions that come with the medication and reach out to their healthcare provider or pharmacist with any questions or concerns
We have found what works in the clinic and have streamlined the process to help as many patients as possible with Compounded GLP-1 Therapy
Whilst these medications commonly cause gastrointestinal side effects including nausea, constipation, and diarrhoea, patients sometimes notice changes in bowel movement colour during treatment
US$ 25410.00
Sold : Login>>
